INTRODUCTION: There has been exponential growth in diagnoses of ductal carcinoma in situ (DCIS) in the past decade, yet little is known about sexual functioning and body image in women after diagnosis of DCIS. This is of particular importance because many of the parallel treatment modalities also used to treat invasive breast cancer, e.g., surgery and hormonal therapy, have been shown to have a detrimental effect on psychosexual function. AIM: The aim was to explore changes in sexual function and body image after diagnosis and treatment of in situ cancer. MAIN OUTCOME MEASURES: Evidence-based self-report measures assessing psychosexual functioning and body image. METHODS: Women diagnosed with DCIS within the past 3 months and who reported being sexually active completed measures assessing various aspects of psychosocial and sexual functioning and body image. Outcomes were evaluated at baseline, 9-, and 18-month time points. All statistical tests were two sided. RESULTS: Three hundred four women completed this prospective survey. Overall, sexual function in women with DCIS appears to be very similar to women in the general population and does not seem to be significantly disrupted by a diagnosis of DCIS. Sexual function and body image were notably stable across the 18-month length of follow-up. Of those patients who underwent mastectomy, there were no differences in sexual satisfaction for patients who had reconstruction compared with patients who did not. CONCLUSION: Although it has been shown that women with DCIS have a number of psychosocial challenges, results from this large-scale prospective study of women suggest that sexual function and body image may not be significantly negatively affected by this diagnosis. Of note, these results were also the case for women who underwent mastectomy and hormonal therapy. These findings are reassuring for both patients and physicians in the context of decision making about treatment options.
INTRODUCTION: There has been exponential growth in diagnoses of ductal carcinoma in situ (DCIS) in the past decade, yet little is known about sexual functioning and body image in women after diagnosis of DCIS. This is of particular importance because many of the parallel treatment modalities also used to treat invasive breast cancer, e.g., surgery and hormonal therapy, have been shown to have a detrimental effect on psychosexual function. AIM: The aim was to explore changes in sexual function and body image after diagnosis and treatment of in situ cancer. MAIN OUTCOME MEASURES: Evidence-based self-report measures assessing psychosexual functioning and body image. METHODS:Women diagnosed with DCIS within the past 3 months and who reported being sexually active completed measures assessing various aspects of psychosocial and sexual functioning and body image. Outcomes were evaluated at baseline, 9-, and 18-month time points. All statistical tests were two sided. RESULTS: Three hundred four women completed this prospective survey. Overall, sexual function in women with DCIS appears to be very similar to women in the general population and does not seem to be significantly disrupted by a diagnosis of DCIS. Sexual function and body image were notably stable across the 18-month length of follow-up. Of those patients who underwent mastectomy, there were no differences in sexual satisfaction for patients who had reconstruction compared with patients who did not. CONCLUSION: Although it has been shown that women with DCIS have a number of psychosocial challenges, results from this large-scale prospective study of women suggest that sexual function and body image may not be significantly negatively affected by this diagnosis. Of note, these results were also the case for women who underwent mastectomy and hormonal therapy. These findings are reassuring for both patients and physicians in the context of decision making about treatment options.
Authors: Stefan Feiten; Jan Dünnebacke; Jochen Heymanns; Hubert Köppler; Jörg Thomalla; Christoph van Roye; Diana Wey; Rudolf Weide Journal: Dtsch Arztebl Int Date: 2014-08-04 Impact factor: 5.594
Authors: Francesco Versace; Jeffrey M Engelmann; Edward F Jackson; Aurelija Slapin; Kristin M Cortese; Therese B Bevers; Leslie R Schover Journal: Brain Imaging Behav Date: 2013-12 Impact factor: 3.978
Authors: Kathryn E Flynn; Li Lin; Jill M Cyranowski; Bryce B Reeve; Jennifer Barsky Reese; Diana D Jeffery; Ashley Wilder Smith; Laura S Porter; Carrie B Dombeck; Deborah Watkins Bruner; Francis J Keefe; Kevin P Weinfurt Journal: J Sex Med Date: 2013-02 Impact factor: 3.802
Authors: Peh Joo Ho; Mikael Hartman; Danny A Young-Afat; Sofie A M Gernaat; Soo Chin Lee; Helena M Verkooijen Journal: PLoS One Date: 2018-02-21 Impact factor: 3.240
Authors: Claire Kim; Laurel Liang; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi Journal: Breast Cancer Res Treat Date: 2017-12-23 Impact factor: 4.872
Authors: Leslie R Schover; Marleen van der Kaaij; Eleonora van Dorst; Carien Creutzberg; Eric Huyghe; Cecilie E Kiserud Journal: EJC Suppl Date: 2014-05-29